Casa Sollievo della Sofferenza
In research, Casa Sollievo della Sofferenza stands highest in Medicine (#3,794 of 10,443 worldwide), Health Sciences (#4,975 of 11,982 worldwide) and Life Sciences (#4,011 of 7,800 worldwide), 2022–2025.
- World rank, 2022–2025
- #8,088 of 28,054 · #6,949 all time
- Rank in Italy
- #223 of 618
- Research works
- 2.4k ▲ 29% vs 2013–17
- Citations
- 60k 25.3 per fractional work
- Top-10% rate
- 17.9% record average 16.5%
- Open access
- 38% world 28%
What is Casa Sollievo della Sofferenza known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #3,794 of 10,443 | 17.4% | 216 | #2274 | |
| Health SciencesDomain | #4,975 of 11,982 | 17.4% | 225 | #2978 | |
| Life SciencesDomain | #4,011 of 7,800 | 18.3% | 89 | #3207 | |
| Biochemistry, Genetics and Molecular BiologyField | #3,291 of 3,579 | 17.7% | 64 | #3670 |
Each strip is that field’s whole ranked pool, with the notch where Casa Sollievo della Sofferenza sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#2,274 #3,794
- Health Sciences#2,978 #4,975
- Life Sciences#3,207 #4,011
- Biochemistry, Genetics and Molecular Biology#3,670 #3,291
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 3.6×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 3.6×
- Medicine 3.3×
- Neuroscience 2.8×
- Immunology and Microbiology 2.2×
- Nursing 1.6×
- Health Professions 0.7×
- Pharmacology, Toxicology and Pharmaceutics 0.6×
- Psychology 0.4×
- Veterinary 0.4×
- Dentistry 0.3×
- Economics, Econometrics and Finance 0.2×
- Mathematics 0.2×
- Chemistry 0.2×
- Materials Science 0.2×
- Computer Science 0.1×
- Environmental Science 0.1×
- Physics and Astronomy 0.1×
- Decision Sciences 0.1×
- Agricultural and Biological Sciences 0.1×
- Engineering 0.1×
- Arts and Humanities 0.1×
- Business, Management and Accounting 0.0×
- Social Sciences 0.0×
Who are the top researchers at Casa Sollievo della Sofferenza?
Ranked on the composite score, Alessandra Mangia, Gianluigi Mazzoccoli and Grazia D’Onofrio lead among researchers whose main affiliation is Casa Sollievo della Sofferenza.
- 1 Alessandra Mangia Italy · #20,648 worldwide 385 citations · 64 works
- 2 Gianluigi Mazzoccoli Italy · #60,908 worldwide 326 citations · 30 works
- 3 Grazia D’Onofrio Italy · #64,206 worldwide 722 citations · 26 works
- 4 Marco Castori Italy · #68,934 worldwide 387 citations · 154 works
- 5 Anna Latiano Italy · #89,255 worldwide 517 citations · 24 works
- 6 Orazio Palmieri Italy · #93,465 worldwide 530 citations · 23 works
- 7 Elvira Grandone Italy · #95,156 worldwide 273 citations · 44 works
- 8 Giuseppe Merla Italy · #107,687 worldwide 323 citations · 24 works
- 9 Davide Seripa Italy · #142,367 worldwide 260 citations · 49 works
- 10 Maurizio Leone Italy · #146,229 worldwide 178 citations · 33 works
Which keywords describe research at Casa Sollievo della Sofferenza?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Chemotherapy, Genetic Mutations, Immunotherapy, Inflammation, Prognostic Factors, Targeted Therapy and Mitochondrial Dysfunction.
- Genomic Instability
- DNA Methylation
- Intervertebral Disc
- Huntington's Disease
- Spinal Surgery
- Protein Aggregation
- Metastasis
- Clinical Outcomes
- Degenerative Disc Disease
- Surgical Treatment
- Neurological Disorders
- Clinical Practice Guidelines
- Clinical Trials
- Biomarkers
- Genetics
- Quality of Life
- Treatment
- Cancer
- Genetic Mutations
- Inflammation
- Epidemiology
- Chemotherapy
- Oxidative Stress
- Immunotherapy
- Prognostic Factors
- Cardiovascular Disease
- Targeted Therapy
- Mitochondrial Dysfunction
- Diagnosis
- Tumor Microenvironment
- Surgical Management
- Low Back Pain
- Radiotherapy
- Genetic Variants
- Spinal Fusion
- Chaperones
- Cell-Free DNA
- Polyglutamine
- Lumbar Disc Degeneration
- Molecular Characterization
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology36▲ 2.8×91 topics
- Inflammation18▲ 2.5×63 topics
- Chemotherapy16▲ 6.9×22 topics
- Genetic Mutations15▲ 10×22 topics
- Oxidative Stress14▲ 2.6×36 topics
- Cancer13▲ 3.0×38 topics
- Immunotherapy13▲ 5.2×17 topics
- Treatment11▲ 2.7×37 topics
- Prognostic Factors11▲ 7.2×14 topics
- Quality of Life10▲ 1.97×31 topics
- Cardiovascular Disease9▲ 2.5×29 topics
- Genetics9▲ 4.0×15 topics
- Targeted Therapy9▲ 12×4 topics
- Biomarkers9▲ 3.9×16 topics
- Mitochondrial Dysfunction9▲ 9.2×10 topics
- Clinical Trials9▲ 4.0×12 topics
- Diagnosis8▲ 2.7×31 topics
- Clinical Practice Guidelines8▲ 4.3×14 topics
- Tumor Microenvironment8▲ 5.3×8 topics
- Neurological Disorders7▲ 3.9×15 topics
- Surgical Management7▲ 4.9×16 topics
- Surgical Treatment7▲ 10×6 topics
- Low Back Pain6▲ 11×2 topics
- Degenerative Disc Disease6▲ 19×2 topics
- Radiotherapy6▲ 4.7×12 topics
- Clinical Outcomes6▲ 8.2×4 topics
- Genetic Variants6▲ 10×7 topics
- Metastasis6▲ 5.0×11 topics
- Spinal Fusion6▲ 17×2 topics
- Protein Aggregation6▲ 31×2 topics
- Chaperones5▲ 28×2 topics
- Spinal Surgery5▲ 21×2 topics
- Cell-Free DNA5▲ 16×2 topics
- Huntington's Disease5▲ 52×1 topic
- Polyglutamine5▲ 52×1 topic
- Intervertebral Disc5▲ 22×1 topic
- Lumbar Disc Degeneration5▲ 22×1 topic
- DNA Methylation5▲ 13×3 topics
- Molecular Characterization5▲ 8.2×5 topics
- Genomic Instability5▲ 13×3 topics
Which research topics does Casa Sollievo della Sofferenza publish most on?
By volume in 2022–2025: Genetic Neurodegenerative Diseases, Spine and Intervertebral Disc Pathology, Cancer Genomics and Diagnostics and Colorectal Cancer Treatments and Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 5 works
- 2 Spine and Intervertebral Disc Pathology Pathology and Forensic Medicine 5 works
- 3 Cancer Genomics and Diagnostics Cancer Research 5 works
- 4 Colorectal Cancer Treatments and Studies Oncology 3 works
- 5 Inflammatory Bowel Disease Genetics 3 works
- 6 Cancer Immunotherapy and Biomarkers Oncology 3 works
- 7 Genomics and Rare Diseases Genetics 3 works
- 8 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
- 9 Epigenetics and DNA Methylation Molecular Biology 2 works
- 10 Pancreatic and Hepatic Oncology Research Oncology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Casa Sollievo della Sofferenza's research output changed?
Output in 2018–2022 was 29% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.